{
    "accession": "MITE9999999",
    "status": "pending",
    "comment": "DUF3328-containing enzyme. AprY sequence tag (AFLA_041390) found in SI pS10 of referenced paper of Ye et al 2018",
    "changelog": [
        {
            "version": "1",
            "date": "2025-11-01",
            "contributors": [
                "0000-0001-6534-6609"
            ],
            "reviewers": [
                "BBBBBBBBBBBBBBBBBBBBBBBB"
            ],
            "comment": "New entry."
        }
    ],
    "enzyme": {
        "name": "AprY",
        "description": "Oxidase",
        "references": [
            "doi:10.1021/jacs.4c18770",
            "doi:10.1039/C8OB02824A"
        ],
        "auxiliaryEnzymes": [
            {
                "name": "AprR",
                "description": "Reductase",
                "databaseIds": {
                    "uniprot": "B8NCG2",
                    "genpept": "EED52435.1"
                }
            }
        ],
        "databaseIds": {
            "uniprot": "B8NCQ4",
            "genpept": "EED52437.1",
            "mibig": "BGC0001306"
        },
        "cofactors": {
            "organic": [
                "Ascorbic acid",
                "NADP"
            ],
            "inorganic": [
                "Cu"
            ]
        }
    },
    "reactions": [
        {
            "tailoring": [
                "Oxidation"
            ],
            "description": "Oxidative cyclization of Y2 and Y6 in the FYYTGY hexapeptide, no leader peptide required. The sequence KRFYYTGYKR did not lead to any products",
            "reactionSMARTS": "[#6:1]\\[#6@:2](-[#6@@:4](\\[#6:41](-[#7:43]-[#6:44]-[#6:45](-[#7:47]/[#6@:48](-[#6:57](-[#8:59])=[#8:58])-[#6:49]-[#6:50]1:[#6:56]:[#6:55]:[#6:53](-[#8:54]):[#6:52]:[#6:51]:1)=[#8:46])=[#8:42])-[#7:5]-[#6:6](\\[#6@@:8](-[#7:17]-[#6:18](/[#6@@:20](-[#7:29]-[#6:30](-[#6@:32](-[#6:34]-[#6:35]1:[#6:40]:[#6:39]:[#6:38]:[#6:37]:[#6:36]:1)/[#7:33])=[#8:31])-[#6:21]-[#6:22]1:[#6:28]:[#6:27]:[#6:25](-[#8:26]):[#6:24]:[#6:23]:1)=[#8:19])-[#6:9]-[#6:10]1:[#6:16]:[#6:15]:[#6:13](-[#8:14]):[#6:12]:[#6:11]:1)=[#8:7])-[#8:3]>>[#6:1]\\[#6@:2](-[#6@:4]1\\[#6:41](-[#7:43]-[#6:44]-[#6:45](-[#7:47]/[#6@:48](-[#6:57](-[#8:59])=[#8:58])-[#6:49]-[#6:50]2:[#6:51]:[#6:52]:[#6:53](-[#8:54]\\[#6@:9](-[#6:10]3:[#6:16]:[#6:15]:[#6:13](-[#8:14]):[#6:12]:[#6:11]:3)-[#6@:8](-[#7:17]-[#6:18](/[#6@@:20](-[#7:29]-[#6:30](-[#6@:32](-[#6:34]-[#6:35]3:[#6:40]:[#6:39]:[#6:38]:[#6:37]:[#6:36]:3)/[#7:33])=[#8:31])-[#6:21]-[#6:22]3:[#6:23]:[#6:24]:[#6:25](-[#8:26]):[#6:27]:[#6:28]:3)=[#8:19])\\[#6:6](=[#8:7])-[#7:5]-1):[#6:55]:[#6:56]:2)=[#8:46])=[#8:42])-[#8:3]",
            "reactions": [
                {
                    "substrate": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O",
                    "products": [
                        "C[C@@H](O)[C@@H]1NC(=O)[C@@H](NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)Cc2ccccc2)[C@@H](c2ccc(O)cc2)Oc2ccc(cc2)C[C@@H](C(=O)O)NC(=O)CNC1=O"
                    ],
                    "isIntermediate": true,
                    "description": "Asperipin-2a intermediate with a single macrocycle"
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "Heterologous expression",
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1021/jacs.4c18770"
                ]
            }
        },
        {
            "tailoring": [
                "Oxidation"
            ],
            "description": "Oxidative cyclization of Y2 and Y6 in the FYYTGY hexapeptide, no leader peptide required. The sequence KRFYYTGYKR did not lead to any products",
            "reactionSMARTS": "[#6:1]\\[#6@:2](-[#6@@:4](\\[#6:41](-[#7:43]-[#6:44]-[#6:45](-[#7:47]/[#6@:48](-[#6:57](-[#8:59])=[#8:58])-[#6:49]-[#6:50]1:[#6:56]:[#6:55]:[#6:53](-[#8:54]):[#6:52]:[#6:51]:1)=[#8:46])=[#8:42])-[#7:5]-[#6:6](\\[#6@@:8](-[#7:17]-[#6:18](/[#6@@:20](-[#7:29]-[#6:30](-[#6@:32](-[#6:34]-[#6:35]1:[#6:40]:[#6:39]:[#6:38]:[#6:37]:[#6:36]:1)/[#7:33])=[#8:31])-[#6:21]-[#6:22]1:[#6:28]:[#6:27]:[#6:25](-[#8:26]):[#6:24]:[#6:23]:1)=[#8:19])-[#6:9]-[#6:10]1:[#6:16]:[#6:15]:[#6:13](-[#8:14]):[#6:12]:[#6:11]:1)=[#8:7])-[#8:3]>>[#6:1]\\[#6@:2](-[#6@:4]1\\[#6:41](-[#7:43]-[#6:44]-[#6:45](-[#7:47]/[#6@:48](-[#6:57](-[#8:59])=[#8:58])-[#6:49]-[#6:50]2:[#6:51]:[#6:52]:[#6:53](-[#8:54]\\[#6@@:9]3-[#6:10]4:[#6:16]:[#6:15]:[#6:13](-[#8:14]/[#6@:34](-[#6:35]5:[#6:40]:[#6:39]:[#6:38]:[#6:37]:[#6:36]:5)-[#6@:32](/[#8])-[#6:30](=[#8:31])-[#7:29]-[#6@@:20](-[#6:21]-[#6:22]5:[#6:23]:[#6:24]:[#6:25](-[#8:26]):[#6:27]:[#6:28]:5)/[#6:18](=[#8:19])-[#7:17]-[#6@@:8]-3\\[#6:6](=[#8:7])-[#7:5]-1):[#6:12]:[#6:11]:4):[#6:55]:[#6:56]:2)=[#8:46])=[#8:42])-[#8:3]",
            "reactions": [
                {
                    "substrate": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O",
                    "products": [
                        "C[C@@H](O)[C@@H]1NC(=O)[C@H]2NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](O)[C@@H](c3ccccc3)Oc3ccc(cc3)[C@H]2Oc2ccc(cc2)C[C@@H](C(=O)O)NC(=O)CNC1=O"
                    ],
                    "isIntermediate": false,
                    "description": "Two-step macrocyclization leading to Asperipin-2a"
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "Heterologous expression",
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1021/jacs.4c18770"
                ]
            }
        },
        {
            "tailoring": [
                "Oxidation"
            ],
            "description": "Oxidative cyclization of Y2 and Y6 in the FYYTGY hexapeptide, no leader peptide required. The sequence KRFYYTGYKR did not lead to any products",
            "reactionSMARTS": "[#6:1]\\[#6@:2](-[#6@@:4](\\[#6:41](-[#7:43]-[#6:44]-[#6:45](-[#7:47]/[#6@:48](-[#6:57](-[#8:59])=[#8:58])-[#6:49]-[#6:50]1:[#6:56]:[#6:55]:[#6:53](-[#8:54]):[#6:52]:[#6:51]:1)=[#8:46])=[#8:42])-[#7:5]-[#6:6](\\[#6@@:8](-[#7:17]-[#6:18](/[#6@@:20](-[#7:29]-[#6:30](-[#6@:32](-[#6:34]-[#6:35]1:[#6:40]:[#6:39]:[#6:38]:[#6:37]:[#6:36]:1)/[#7:33])=[#8:31])-[#6:21]-[#6:22]1:[#6:28]:[#6:27]:[#6:25](-[#8:26]):[#6:24]:[#6:23]:1)=[#8:19])-[#6:9]-[#6:10]1:[#6:16]:[#6:15]:[#6:13](-[#8:14]):[#6:12]:[#6:11]:1)=[#8:7])-[#8:3]>>[#6:1]\\[#6@:2](-[#6@:4]1\\[#6:41](-[#7:43]-[#6:44]-[#6:45](-[#7:47]/[#6@:48](-[#6:57](-[#8:59])=[#8:58])-[#6:49]-[#6:50]2:[#6:51]:[#6:52]:[#6:53](-[#8:54]\\[#6@@:9]3-[#6:10]4:[#6:16]:[#6:15]:[#6:13](-[#8:14]/[#6@:34](-[#6:35]5:[#6:40]:[#6:39]:[#6:38]:[#6:37]:[#6:36]:5)-[#6@:32](/[#7:33])-[#6:30](=[#8:31])-[#7:29]-[#6@@:20](-[#6:21]-[#6:22]5:[#6:23]:[#6:24]:[#6:25](-[#8:26]):[#6:27]:[#6:28]:5)/[#6:18](=[#8:19])-[#7:17]-[#6@@:8]-3\\[#6:6](=[#8:7])-[#7:5]-1):[#6:12]:[#6:11]:4):[#6:55]:[#6:56]:2)=[#8:46])=[#8:42])-[#8:3]",
            "reactions": [
                {
                    "substrate": "C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O",
                    "products": [
                        "C[C@@H](O)[C@@H]1NC(=O)[C@H]2NC(=O)[C@H](Cc3ccc(O)cc3)NC(=O)[C@@H](N)[C@@H](c3ccccc3)Oc3ccc(cc3)[C@H]2Oc2ccc(cc2)C[C@@H](C(=O)O)NC(=O)CNC1=O"
                    ],
                    "isIntermediate": false,
                    "description": "Two-step macrocyclization leading to Asperipin-2a-like molecule with N-terminal amine "
                }
            ],
            "evidence": {
                "evidenceCode": [
                    "Heterologous expression",
                    "In vitro assay"
                ],
                "references": [
                    "doi:10.1021/jacs.4c18770"
                ]
            }
        }
    ]
}